? TGen connected with leaders throughout the institute to share their advice and insights as women trailblazing in research. Here is what Manasa Upadhyaya, a bioinformatician in the Tomasetti/Lahouel Lab shared ??
TGen - Part of City of Hope
生物技术研究
Phoenix，AZ 10,954 位关注者
Our scientists study a patient’s DNA blueprint to find the causes of cancer and develop smarter treatments for it.
关于我们
TGen, a part of City of Hope, is a non-profit 501(c)(3) organization focused on developing earlier diagnostics and smarter treatments. Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics and treatments for cancer, neurological disorders, rare childhood disorders, infectious disease and other complex conditions. Stay up-to-date: tgen.org/subscribe
- 网站
-
https://www.tgen.org
TGen - Part of City of Hope的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- Phoenix，AZ
- 类型
- 非营利机构
- 创立
- 2002
- 领域
- Genomics、Research、Translational Medicine、Education、Neurological Disorders、Pathogens and Microbiome、Metabolic and Fibrotic Diseases、Next Generation Technology、Artificial Intelligence、Alzheimer's Disease、Pancreatic Cancer、Brain Cancer、Breast Cancer、Rare Disorders、Ovarian Cancer、Precision Aging、Infectious Disease和Diabetes
地点
-
主要
获取路线
445 N. Fifth Street
Suite 600
US，AZ，Phoenix，85004
TGen - Part of City of Hope员工
动态
-
We're taking a leap to BlueSky and sharing the impact of research and related insights. Follow along and interact with us at TGenResearch.BSKY.Social or search TGenResearch ??
-
-
When your child is sick, you hope for clear answers. But what if there aren’t any? The uncertainty, fear, and frustration can feel overwhelming. ?? No parent is ever truly prepared for the weight of medical uncertainty, but you are not alone. There are ways to navigate this journey—with resilience, support, and hope. At TGen's Center for Rare Childhood Disorders, we’re committed to bridging the gap between cutting-edge genomic discoveries and personalized care. ?? Read the full blog at: https://lnkd.in/gFSH9qdt
-
-
TGen - Part of City of Hope转发了
"This is a pretty significant jump, having this modularity. You can start to add a lot of capabilities at one time into one run," Nicholas Banovich, a researcher at the TGen - Part of City of Hope who is looking to adopt #AVITI24, told GenomeWeb. "You have a workflow where you have 300 cycles, and you can plug and play these different capabilities in there, adding modules in until you get to the cycle maximum." Our Innovation Roadmap for AVITI24? was recently?highlighted in GenomeWeb. It is inspiring to see how initial users are beginning to utilize our first-of-its-kind #multiomics platform. We look forward to seeing how the scientific community continues to apply and innovate with AVITI24! Read the full article: https://bit.ly/4iHYjDl #ElemBio?#Genomics
-
TGen's Nicholas Banovich recently presented at the AGBT Gold Sponsor Workshop on Illumina's spatial technology. Using spatial transcriptomics has allowed TGen to expand our research to identify better and localize changes in cells, particularly in pulmonary fibrosis studies.
Yesterday at our AGBT Gold Sponsor Workshop, customers joined us on stage to share early data and insights from one of our latest innovations: Illumina spatial technology. They shared how the differentiated scale and resolution of this technology is already driving new insights: "Our early analyses with this technology identified and localized molecular dysregulation associated with active epithelial cell remodeling in pulmonary fibrosis. We believe this will aid in identifying therapeutic targets which can be used to stop or slow the progression of disease."?-?Nicholas Banovich, PhD, at TGen - Part of City of Hope "With this new technology we were able to profile millions of cells on just two substrates and found biomarkers that are not included in targeted approaches." -?Jasmine Plummer, PhD, at St. Jude Children's Research Hospital "Large-scale and unbiased whole-transcriptome capture are the ideal components of a discovery platform capable of finding novel marker genes and simultaneously validating them across multiple tissue sections within a single experiment."?-?Michal Lipinski, PhD, at the Broad Institute of MIT and Harvard Missed the Gold Sponsor workshop? Register here to get the recording: https://bit.ly/3X4o4Ft
-
-
Congratulations to Kimberly Olney, PhD for taking home the title at PacBio's SMRT Pitch – Rockies Edition! ?? ?? Her groundbreaking research on Alzheimer’s and Lewy body dementia earned her up to $75K in sequencing resources to study how gene isoform changes impact these diseases. This work could help improve diagnosis and treatment for millions affected by dementia.
-
-
A day in the life with Megan Locklear ?? Follow along as she shares what a day looks like as an IVY Scholar Intern focused on brain tumor research! ?? https://lnkd.in/gBk7a7fv
A Day in the Life of an IVY Scholar Intern, Megan! ?? #IVYScholar #dayinthelifewithanewborn
https://www.youtube.com/
-
Dr. Aleksandar Sekulic, a leading expert in skin cancer research and treatment, has been appointed as Physician-in-Chief at TGen, part of City of Hope. With a passion for collaboration, precision medicine and groundbreaking therapies, Dr. Sekulic’s leadership will continue to help drive innovation in cancer care and genomics research. Join us in welcoming him to this new role! ?? #CancerResearch #PrecisionMedicine #TGen #CityofHope #ThoughtLeader
-
-
TGen is lucky to have such passionate and dedicated principal investigators leading in the research arena. Congrats to Vinodh Narayanan, M.D., for being selected as the 2025 Roger & Mary Memorial Lifetime Achievement award at the Child Neurology Society ??
So proud of my boss and mentor, Dr. Vinodh Narayanan, for winning the 2025 Roger & Mary Brumback Memorial Lifetime Achievement Award from the Child Neurology Society. The award is presented to CNS Members to recognize a life-long commitment to child neurology, patient care, and humanism in medicine. Narayanan, Vinodh
-